View Infographic. Researchers are working to develop RSV vaccines, but none are available yet. A drug called palivizumab pah-lih-VIH-zu-mahb is available to prevent severe RSV illness in certain infants and children who are at high risk for severe disease. This could include, for example, infants born prematurely or with congenital present from birth heart disease or chronic lung disease.
The drug can help prevent serious RSV disease, but it cannot help cure or treat children already suffering from serious RSV disease, and it cannot prevent infection with RSV. If your child is at high risk for severe RSV disease, talk to your healthcare provider to see if palivizumab can be used as a preventive measure. Skip directly to site content Skip directly to page options Skip directly to A-Z link. Section Navigation. Directly by respiratory secretions, inhalation of large droplets, fomites, and oral contact.
Indirectly by hands, articles soiled by respiratory or nasal secretions. Growth Conditions Human epithelial cell lines HEp These groups include premature infants, immunocompromised individuals and children with cyanotic congenital heart disease. Surveillance Monitor symptoms. Emory Requirements Report all exposures. However, it is likely that many LAIs occur but have not been reported due to the difficulty to link it back to the laboratory cause Sources Nasal washes and secretions, nasopharyngeal swabs.
Growth of respiratory syncytial virus in primary epithelial cells from the human respiratory tract. Skip directly to site content Skip directly to page options Skip directly to A-Z link. Section Navigation.
Facebook Twitter LinkedIn Syndicate. RSV Transmission. Minus Related Pages. Links with this icon indicate that you are leaving the CDC website.
0コメント